BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37869238)

  • 41. [Effect of concurrent chemoradiotherapy and radiotherapy alone on peripheral myeloid-derived suppressor and T regulatory cells in patients with nasopharyngeal cancer].
    Dai XC; Liu LQ; Wang BH; Wang CM; Ma L; Cao WM; Dai EX
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):579-583. PubMed ID: 28835079
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypoxia-/HIF-1α-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression.
    Vaupel P; Multhoff G
    Adv Exp Med Biol; 2018; 1072():171-175. PubMed ID: 30178341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.
    Draghiciu O; Lubbers J; Nijman HW; Daemen T
    Oncoimmunology; 2015 Jan; 4(1):e954829. PubMed ID: 25949858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of YAP confers radioresistance to esophageal cancer by altering the tumor microenvironment.
    Yao G; Shao M; Nie Y; Zhang W; Yang Z; Li Q
    Environ Toxicol; 2024 Feb; ():. PubMed ID: 38375610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma.
    Chen YP; Yin JH; Li WF; Li HJ; Chen DP; Zhang CJ; Lv JW; Wang YQ; Li XM; Li JY; Zhang PP; Li YQ; He QM; Yang XJ; Lei Y; Tang LL; Zhou GQ; Mao YP; Wei C; Xiong KX; Zhang HB; Zhu SD; Hou Y; Sun Y; Dean M; Amit I; Wu K; Kuang DM; Li GB; Liu N; Ma J
    Cell Res; 2020 Nov; 30(11):1024-1042. PubMed ID: 32686767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emerging role of natural products in cancer immunotherapy.
    Dong S; Guo X; Han F; He Z; Wang Y
    Acta Pharm Sin B; 2022 Mar; 12(3):1163-1185. PubMed ID: 35530162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
    Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
    Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catalase-gold nanoaggregates manipulate the tumor microenvironment and enhance the effect of low-dose radiation therapy by reducing hypoxia.
    Najafi A; Keykhaee M; Kazemi MH; Karimi MY; Khorramdelazad H; Aghamohamadi N; Bolouri MR; Ghaffari-Nazari H; Mirsharif ES; Karimi M; Dehghan Manshadi HR; Mahdavi SR; Safari E; Jalali SA; Falak R; Khoobi M
    Biomed Pharmacother; 2023 Nov; 167():115557. PubMed ID: 37757491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Impact of Estrogen in the Tumor Microenvironment.
    Somasundaram A; Rothenberger NJ; Stabile LP
    Adv Exp Med Biol; 2020; 1277():33-52. PubMed ID: 33119863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Research of SIRT1 on promoting the proliferation, migration and lipid metabolism of nasopharyngeal carcinoma].
    Yin HM; He X; Shan Y; Zhai HX; Zhang KW; Xia T; Zhang SY; Chen WH; You YW
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Oct; 55(10):934-943. PubMed ID: 33036508
    [No Abstract]   [Full Text] [Related]  

  • 51. Hypoxia, a key factor in the immune microenvironment.
    Hu J; Li X; Yang L; Li H
    Biomed Pharmacother; 2022 Jul; 151():113068. PubMed ID: 35676780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant frequency of TNFR2-expressing CD4+ FoxP3+ regulatory T cells in nasopharyngeal carcinoma patients.
    Engku Abd Rahman ENS; Irekeola AA; Shueb RH; Mat Lazim N; Mohamud R; Chen X; Ghazali L; Awang NMSH; Haron A; Chan YY
    Cytokine; 2023 Oct; 170():156341. PubMed ID: 37657236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypoxia-Induced Matrix Metalloproteinase-13 Expression in Exosomes from Nasopharyngeal Carcinoma Enhances Metastases.
    Shan Y; You B; Shi S; Shi W; Zhang Z; Zhang Q; Gu M; Chen J; Bao L; Liu D; You Y
    Cell Death Dis; 2018 Mar; 9(3):382. PubMed ID: 29515112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.
    Peng F; Xu Z; Wang J; Chen Y; Li Q; Zuo Y; Chen J; Hu X; Zhou Q; Wang Y; Ma H; Bao Y; Chen M
    PLoS One; 2012; 7(4):e34646. PubMed ID: 22496834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PI3Kγδ inhibitor plus radiation enhances the antitumour immune effect of PD-1 blockade in syngenic murine breast cancer and humanised patient-derived xenograft model.
    Han MG; Jang BS; Kang MH; Na D; Kim IA
    Eur J Cancer; 2021 Nov; 157():450-463. PubMed ID: 34601286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment.
    Gong L; Kwong DL; Dai W; Wu P; Wang Y; Lee AW; Guan XY
    Front Oncol; 2021; 11():744889. PubMed ID: 34568077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PGE2-HIF1α reciprocal induction regulates migration, phenotypic alteration and immunosuppressive capacity of macrophages in tumor microenvironment.
    Saha J; Sarkar D; Pramanik A; Mahanti K; Adhikary A; Bhattacharyya S
    Life Sci; 2020 Jul; 253():117731. PubMed ID: 32353431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment.
    Wang X; Zhang Y; Mu X; Tu CR; Chung Y; Tsao SW; Chan GC; Leung WH; Lau YL; Liu Y; Tu W
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35105688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives.
    Su ZY; Siak PY; Leong CO; Cheah SC
    Front Oncol; 2022; 12():840467. PubMed ID: 35311066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models.
    Katsuta E; Rashid OM; Takabe K
    Hum Cell; 2020 Oct; 33(4):930-937. PubMed ID: 32507979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.